Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06815302 · ClinicalTrials.gov registry record · NA

TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD

A NA study of Parkinson Disease and Freezing of Gait Symptoms in Parkinson Disease, sponsored by Oregon Health and Science University.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
3
Study locations

NCT06815302: Recruiting NA study of Parkinson Disease and Freezing of Gait Symptoms in Parkinson Disease, sponsored by Oregon Health and Science University.

NCT06815302 is a NA study of Parkinson Disease and Freezing of Gait Symptoms in Parkinson Disease that is actively recruiting participants, run by Oregon Health and Science University. The registered enrollment target is 60 participants, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06815302, a NA study of Parkinson Disease and Freezing of Gait Symptoms in Parkinson Disease, is actively recruiting participants, sponsored by Oregon Health and Science University.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
3
Study locations

Study Summary

The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention can reduce FOG and improve daily life mobility in people with FOG sufficiently to justify a clinical trial. Participants will: * Be randomly assigned to one of two intervention groups (turning-focused agility exercise or strength-based exercise) * Have one-on-one training sessions three times per week for 6 weeks * Perform in-lab assessments before beginning and after completing the study intervention * Use wearable mobility sensors during daily life to measure their walking and balance

Primary Outcome

Change in freezing of gait severity with the intervention (scored in likert scale by the patient; 3 = Much improved, 2 = Somewhat improved, 1 = Minimally improved, 0 = No change, -1 = Minimally worse, -2 = Somewhat worse, -3 = Much worse)

Interventions

  • BEHAVIORAL Experimental intervention
  • BEHAVIORAL Active intervention

Study Locations (3)

Arizona

  • Arizona State University - Tempe

Oregon

  • Oregon Health and Science University - Portland

São Paulo

  • University of São Paulo, Bauru Campus - Bauru

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2025-06-02
Est. Completion 2027-06-30
Phase NA

What NCT06815302 shows while recruiting

NCT06815302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 5,326-participant average among 297 other Parkinson Disease trials with a reported enrollment target (99% lower).

The record links to 2 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 2 interventions - of which Experimental intervention is the first listed.

NCT06815302 reports a single indexed study location in Arizona, Oregon, São Paulo.

Frequently Asked Questions

What is clinical trial NCT06815302 about?

NCT06815302 is a clinical study titled "TURN-IT FOG: Improving Turning and Freezing of Gait in People With PD". The goals of this clinical trial are to 1) learn how two different rehabilitation interventions for PD can reduce Freezing of Gait (FOG) in people with Parkinson's disease, as assessed by patients, clinicians, and wearable sensors, and 2) to explore whether two different rehabilitation intervention ...

What is the current status of trial NCT06815302?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-06-02. Estimated completion is 2027-06-30.

What conditions does trial NCT06815302 study?

This clinical trial studies the following conditions: Parkinson Disease, Freezing of Gait Symptoms in Parkinson Disease.

What interventions are being tested in trial NCT06815302?

The interventions under investigation include: Experimental intervention (BEHAVIORAL), Active intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT06815302?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06815302 being conducted?

This trial has 3 study locations across Arizona, Oregon, São Paulo. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06815302's enrollment target sits among peer trials

60 125th of 297 higher than 154 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

  • NCT02114450 · 60 participants · NA

    Human-Machine System for the H2 Lower Limb Exoskeleton

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06815302, the US trial registry maintained by the National Library of Medicine. NCT06815302 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.